These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 36929126)
1. Children with Localized Crohn's Disease Benefit from Early Ileocecal Resection and Perioperative Anti-Tumor Necrosis Factor Therapy. Weigl E; Schwerd T; Lurz E; Häberle B; Koletzko S; Hubertus J Eur J Pediatr Surg; 2024 Jun; 34(3):236-244. PubMed ID: 36929126 [TBL] [Abstract][Full Text] [Related]
2. Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: retrospective long-term follow-up of the LIR!C trial. Stevens TW; Haasnoot ML; D'Haens GR; Buskens CJ; de Groof EJ; Eshuis EJ; Gardenbroek TJ; Mol B; Stokkers PCF; Bemelman WA; Ponsioen CY; Lancet Gastroenterol Hepatol; 2020 Oct; 5(10):900-907. PubMed ID: 32619413 [TBL] [Abstract][Full Text] [Related]
3. Early Initiation of Antitumor Necrosis Factor Therapy Reduces Postoperative Recurrence of Crohn's Disease Following Ileocecal Resection. Axelrad JE; Li T; Bachour SP; Nakamura TI; Shah R; Sachs MC; Chang S; Hudesman DP; Holubar SD; Lightner AL; Barnes EL; Cohen BL; Rieder F; Esen E; Remzi F; Regueiro M; Click B Inflamm Bowel Dis; 2023 Jun; 29(6):888-897. PubMed ID: 35905032 [TBL] [Abstract][Full Text] [Related]
4. Previous Exposure to Multiple Anti-TNF Is Associated with Decreased Efficiency in Preventing Postoperative Crohn's Disease Recurrence. Collins M; Sarter H; Gower-Rousseau C; Koriche D; Libier L; Nachury M; Cortot A; Zerbib P; Blanc P; Desreumaux P; Colombel JF; Peyrin-Biroulet L; Pineton de Chambrun G J Crohns Colitis; 2017 Mar; 11(3):281-288. PubMed ID: 27578800 [TBL] [Abstract][Full Text] [Related]
5. Endoscopic Recurrence 6 Months After Ileocecal Resection in Children With Crohn Disease Treated With Azathioprine. Zarubova K; Hradsky O; Copova I; Rouskova B; Pos L; Skaba R; Bronsky J J Pediatr Gastroenterol Nutr; 2017 Aug; 65(2):207-211. PubMed ID: 28248209 [TBL] [Abstract][Full Text] [Related]
6. Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: a randomised controlled, open-label, multicentre trial. Ponsioen CY; de Groof EJ; Eshuis EJ; Gardenbroek TJ; Bossuyt PMM; Hart A; Warusavitarne J; Buskens CJ; van Bodegraven AA; Brink MA; Consten ECJ; van Wagensveld BA; Rijk MCM; Crolla RMPH; Noomen CG; Houdijk APJ; Mallant RC; Boom M; Marsman WA; Stockmann HB; Mol B; de Groof AJ; Stokkers PC; D'Haens GR; Bemelman WA; Lancet Gastroenterol Hepatol; 2017 Nov; 2(11):785-792. PubMed ID: 28838644 [TBL] [Abstract][Full Text] [Related]
7. Direct retrospective comparison of adalimumab and infliximab in preventing early postoperative endoscopic recurrence after ileocaecal resection for crohn's disease: results from the MULTIPER database. Kotze PG; Yamamoto T; Danese S; Suzuki Y; Teixeira FV; de Albuquerque IC; Saad-Hossne R; de Barcelos IF; da Silva RN; da Silva Kotze LM; Olandoski M; Sacchi M; Yamada A; Takeuchi K; Spinelli A J Crohns Colitis; 2015 Jul; 9(7):541-7. PubMed ID: 25820017 [TBL] [Abstract][Full Text] [Related]
8. Visceral adiposity and inflammatory bowel disease. Rowan CR; McManus J; Boland K; O'Toole A Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989 [TBL] [Abstract][Full Text] [Related]
9. Perioperative anti-tumor necrosis factor therapy does not increase the rate of early postoperative complications in Crohn's disease. Nasir BS; Dozois EJ; Cima RR; Pemberton JH; Wolff BG; Sandborn WJ; Loftus EV; Larson DW J Gastrointest Surg; 2010 Dec; 14(12):1859-65; discussion 1865-6. PubMed ID: 20872084 [TBL] [Abstract][Full Text] [Related]
10. Long-term outcome after ileocecal resection for Crohn's disease. Kim NK; Senagore AJ; Luchtefeld MA; MacKeigan JM; Mazier WP; Belknap K; Chen SH Am Surg; 1997 Jul; 63(7):627-33. PubMed ID: 9202538 [TBL] [Abstract][Full Text] [Related]
11. Postoperative Complications after Ileocecal Resection in Crohn's Disease: A Prospective Study From the REMIND Group. Fumery M; Seksik P; Auzolle C; Munoz-Bongrand N; Gornet JM; Boschetti G; Cotte E; Buisson A; Dubois A; Pariente B; Zerbib P; Chafai N; Stefanescu C; Panis Y; Marteau P; Pautrat K; Sabbagh C; Filippi J; Chevrier M; Houze P; Jouven X; Treton X; Allez M; Am J Gastroenterol; 2017 Feb; 112(2):337-345. PubMed ID: 27958285 [TBL] [Abstract][Full Text] [Related]
12. Retreatment with anti-tumor necrosis factor therapy in combination with an immunomodulator for recurrence of Crohn's disease after ileocecal resection results in prolonged continuation as compared to anti-tumor necrosis factor monotherapy. Ten Bokkel Huinink S; Beelen EMJ; Ten Bokkel Huinink T; Hoentjen F; G L Bodelier A; Dijkstra G; Romberg-Camps M; de Boer NK; Stassen LPS; van der Meulen AE; West R; van Ruler O; van der Woude CJ; de Vries AC; Eur J Gastroenterol Hepatol; 2023 Jan; 35(1):45-51. PubMed ID: 36468568 [TBL] [Abstract][Full Text] [Related]
13. Early Ileocecal Resection for Crohn's Disease Is Associated With Improved Long-term Outcomes Compared With Anti-Tumor Necrosis Factor Therapy: A Population-Based Cohort Study. Agrawal M; Ebert AC; Poulsen G; Ungaro RC; Faye AS; Jess T; Colombel JF; Allin KH Gastroenterology; 2023 Oct; 165(4):976-985.e3. PubMed ID: 37321356 [TBL] [Abstract][Full Text] [Related]
14. Complications and Disease Recurrence After Primary Ileocecal Resection in Pediatric Crohn's Disease: A Multicenter Cohort Analysis. Diederen K; de Ridder L; van Rheenen P; Wolters VM; Mearin ML; Damen GM; de Meij TG; van Wering H; Tseng LA; Oomen MW; de Jong JR; Sloots CE; Benninga MA; Kindermann A Inflamm Bowel Dis; 2017 Feb; 23(2):272-282. PubMed ID: 28079626 [TBL] [Abstract][Full Text] [Related]
15. Long-term outcomes after elective ileocecal resection in children with active localized Crohn's disease--a multicenter European study. Hojsak I; Kolacek S; Hansen LF; Bronsky J; Piekkala M; Lionetti P; Skaba R; Kolho KL J Pediatr Surg; 2015 Oct; 50(10):1630-5. PubMed ID: 25913894 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of Infliximab in Crohn's Disease Patients with Prior Primary-Nonresponse to Tumor Necrosis Factor Antagonists. Clark-Snustad KD; Singla A; Lee SD Dig Dis Sci; 2019 Jul; 64(7):1952-1958. PubMed ID: 30815825 [TBL] [Abstract][Full Text] [Related]
17. Comparable outcomes of the consistent use versus switched use of anti- tumor necrosis factor agents in postoperative recurrent Crohn's disease following ileocolonic resection. Li Y; Stocchi L; Rui Y; Remzi FH; Shen B Int J Colorectal Dis; 2016 Nov; 31(11):1751-1758. PubMed ID: 27475090 [TBL] [Abstract][Full Text] [Related]